基因名 | 疾病 | 靶向药 | 化疗药 | 基因突变 | 临床解释 |
---|---|---|---|---|---|
RMI2 | 0 | 0 | |||
RNASEL | 0 | 0 | |||
RNF19A | 0 | 0 | |||
RNF213 | 0 | 0 | |||
RNF43 | 0 | 0 | |||
ROBO1 | 0 | 0 | |||
ROBO2 | 0 | 0 | |||
ROBO3 | 0 | 0 | |||
ROBO4 | 癌症 | Antiangiogenic Therapy, | 1 | 1 | |
ROCK1 | 0 | 0 | |||
ROCK2 | 0 | 0 | |||
ROS1 | 支气管肺泡腺癌,癌,大肠癌,多形胶质母细胞瘤,炎性肌成纤维细胞瘤,肺腺癌,非小细胞肺癌 | AZD3463,布加替尼,卡博替尼,色瑞替尼,塞瑞替尼,克唑替尼,恩曲替尼,Foretinib,吉非替尼,劳拉替尼,TAE684, | 12 | 31 | |
RP1L1 | 0 | 0 | |||
RPA1 | 0 | 0 | |||
RPA4 | 0 | 0 | |||
RPGR | 0 | 0 | |||
RPL11 | 0 | 0 | |||
RPL22 | 0 | 0 | |||
RPL35A | 0 | 0 | |||
RPL5 | 0 | 0 | |||
RPP30 | 0 | 0 | |||
RPS10 | 0 | 0 | |||
RPS14 | 0 | 0 | |||
RPS17 | 0 | 0 | |||
RPS19 | 0 | 0 | |||
RPS24 | 0 | 0 | |||
RPS26 | 0 | 0 | |||
RPS29 | 0 | 0 | |||
RPS6 | 胃腺癌 | 依维莫司, | 1 | 1 | |
RPS6KA1 | 0 | 0 | |||
RPS6KA3 | 0 | 0 | |||
RPS6KA4 | 0 | 0 | |||
RPS6KB1 | 0 | 0 | |||
RPS6KB2 | 0 | 0 | |||
RPS7 | 0 | 0 | |||
RPTOR | 0 | 0 | |||
RRAGC | 0 | 0 | |||
RRAS | 0 | 0 | |||
RRAS2 | 0 | 0 | |||
RRM1 | 非小细胞肺癌,胰腺癌 | Cisplatine,PLATINUM, | 顺铂,多西他赛,吉西他滨,吉西他滨,顺铂,紫杉醇,长春瑞滨, | 2 | 9 |
RRM2 | 胰腺癌 | 吉西他滨, | 1 | 1 | |
RRP1B | 0 | 0 | |||
RSF1 | 乳腺癌 | 他莫昔芬, | 1 | 1 | |
RSPO2 | 0 | 0 | |||
RSPO3 | 0 | 0 | |||
RTEL1 | 0 | 0 | |||
RUFY4 | 0 | 0 | |||
RUNX1 | 急性淋巴细胞性白血病,急性髓性白血病,骨髓增生异常综合征 | 阿糖胞苷, | 7 | 13 | |
RUNX1T1 | 0 | 0 | |||
RUNX2 | 0 | 0 | |||
RUNX3 | 0 | 0 | |||
RXRA | 0 | 0 | |||
RXRB | 0 | 0 | |||
RXRG | 0 | 0 | |||
RYBP | 0 | 0 | |||
RYR1 | 0 | 0 | |||
RYR2 | 0 | 0 | |||
RYR3 | 0 | 0 | |||
SALL1 | 0 | 0 | |||
SAMD9 | 0 | 0 | |||
SASH1 | 0 | 0 | |||
SATB2 | 0 | 0 | |||
SBDS | 0 | 0 | |||
SBNO2 | 0 | 0 | |||
SCG5 | 0 | 0 | |||
SCN8A | 肺腺癌 | 派姆单抗(帕博利珠单抗), | 1 | 1 | |
SCUBE2 | 0 | 0 | |||
SDC4 | 0 | 0 | |||
SDCCAG8 | 0 | 0 | |||
SDHA | 0 | 0 | |||
SDHAF2 | 0 | 0 | |||
SDHB | 副神经节瘤 | 1 | 1 | ||
SDHC | 0 | 0 | |||
SDHD | 0 | 0 | |||
SEC31A | 0 | 0 | |||
SEL1L3 | 0 | 0 | |||
SEMA3A | 0 | 0 | |||
SEMA3C | 0 | 0 | |||
SEMA3E | 0 | 0 | |||
SEMA6A | 0 | 0 | |||
Sept14 | 0 | 0 | |||
Sept9 | 0 | 0 | |||
SERP2 | 0 | 0 | |||
SERPINA7 | 0 | 0 | |||
SERPINB3 | 0 | 0 | |||
SERPINB4 | 0 | 0 | |||
SESN1 | 0 | 0 | |||
SESN2 | 0 | 0 | |||
SESN3 | 0 | 0 | |||
SETBP1 | 慢性粒细胞白血病,少年粒细胞白血病 | 3 | 3 | ||
SETD2 | 0 | 0 | |||
SETDB1 | 0 | 0 | |||
SETMAR | 0 | 0 | |||
SF1 | 0 | 0 | |||
SF3A1 | 0 | 0 | |||
SF3A3 | 0 | 0 | |||
SF3B1 | 乳腺癌,慢性淋巴细胞白血病,骨髓增生异常综合征 | Spliceostatin A, | 3 | 9 | |
SFPQ | 0 | 0 | |||
SFXN4 | 0 | 0 | |||
SGCZ | 0 | 0 | |||
SGK1 | 乳腺癌 | 阿培利司,SGK1-Inh, | 1 | 3 | |
SH2B3 | 结直肠癌 | 1 | 1 | ||
SH2D1A | 0 | 0 | |||
SH2D2A | 0 | 0 | |||
SH3PXD2A | 0 | 0 | |||
SHBG | 0 | 0 | |||
SHH | 0 | 0 | |||
SHMT1 | 0 | 0 | |||
SHOC2 | 0 | 0 | |||
SHPRH | 0 | 0 | |||
SHQ1 | 0 | 0 | |||
SHROOM3 | 0 | 0 | |||
SI | 0 | 0 | |||
SIK1 | 0 | 0 | |||
SIMC1 | 0 | 0 | |||
SIN3A | 0 | 0 | |||
SIPA1 | 0 | 0 | |||
SIPA1L2 | 0 | 0 | |||
SIRT1 | 胰腺癌 | 烟酰胺, | 1 | 2 | |
SIX1 | 0 | 0 | |||
SKP2 | 0 | 0 | |||
SLAMF7 | 0 | 0 | |||
SLC10A2 | 0 | 0 | |||
SLC14A2 | 0 | 0 | |||
SLC16A1 | 0 | 0 | |||
SLC16A7 | 0 | 0 | |||
SLC19A1 | 0 | 0 | |||
SLC1A2 | 0 | 0 | |||
SLC22A16 | 0 | 0 | |||
SLC22A18 | 0 | 0 | |||
SLC22A2 | 0 | 0 | |||
SLC22A3 | 0 | 0 | |||
SLC22A4 | 0 | 0 | |||
SLC28A3 | 0 | 0 | |||
SLC30A5 | 0 | 0 | |||
SLC31A1 | 0 | 0 | |||
SLC34A2 | 0 | 0 | |||
SLC3A2 | 0 | 0 | |||
SLC45A2 | 0 | 0 | |||
SLC45A3 | 0 | 0 | |||
SLC4A1 | 0 | 0 | |||
SLC6A3 | 0 | 0 | |||
SLC7A8 | 0 | 0 | |||
SLC8A1 | 0 | 0 | |||
SLCO1B1 | 癌症 | 甲氨蝶呤, | 2 | 2 | |
SLCO1B3 | 0 | 0 | |||
SLFN11 | 结直肠癌,尤因肉瘤,小细胞肺癌 | 尼拉帕尼,SN-38,他拉唑帕尼,替莫唑胺, | 1 | 3 | |
SLIT1 | 0 | 0 | |||
SLIT2 | 0 | 0 | |||
SLIT3 | 0 | 0 | |||
SLITRK1 | 0 | 0 | |||
SLITRK2 | 0 | 0 | |||
SLITRK3 | 0 | 0 | |||
SLX1A | 0 | 0 | |||
SLX4 | 0 | 0 | |||
SMAD2 | 0 | 0 | |||
SMAD3 | 0 | 0 | |||
SMAD4 | 结直肠癌,头颈鳞状细胞癌,青少年息肉综合征,非小细胞肺癌,胰腺腺癌,胰腺癌,胰管腺癌,前列腺癌 | 西妥昔单抗,帕尼单抗, | 氟尿嘧啶,吉西他滨,赖氨酸, | 7 | 15 |
SMAD7 | 0 | 0 | |||
SMARCA1 | 0 | 0 | |||
SMARCA2 | 0 | 0 | |||
SMARCA4 | 肺腺癌,非小细胞肺癌,卵巢小细胞癌,卵巢小细胞癌高钙型,实体瘤 | 玻玛西林,玻玛西尼,哌柏西利,帕博西尼,帕博西林,瑞博西尼,他泽司他,Tozasertib(MK-0457,VX-680), | 顺铂,长春瑞滨, | 4 | 8 |
SMARCAL1 | 0 | 0 | |||
SMARCB1 | 横纹肌样癌,实体瘤,滑膜肉瘤 | 他泽司他,帕比司他,他泽司他, | 2 | 4 | |
SMARCC1 | 0 | 0 | |||
SMARCC2 | 0 | 0 | |||
SMARCD1 | 0 | 0 | |||
SMARCE1 | 0 | 0 | |||
SMC1A | 0 | 0 | |||
SMC1B | 0 | 0 | |||
SMC3 | 0 | 0 | |||
SMCHD1 | 0 | 0 | |||
SMO | 基底细胞癌,脑髓母细胞瘤,癌,非小细胞肺癌,髓母细胞瘤,脑膜瘤,嗅槽型脑膜瘤 | 吉非替尼,LDE225,PSI,Saridegib,维莫德吉, | 三氧化二砷, | 18 | 35 |
SMURF2 | 0 | 0 | |||
SMYD3 | 0 | 0 | |||
SNAI1 | 0 | 0 | |||
SNAI2 | 0 | 0 | |||
SNCAIP | 0 | 0 | |||
SNTG1 | 0 | 0 | |||
SNX29 | 0 | 0 | |||
SNX6 | 0 | 0 | |||
SOCS1 | 0 | 0 | |||
SOD2 | 0 | 0 | |||
SORBS2 | 0 | 0 | |||
SOS1 | 0 | 0 | |||
SOX1 | 0 | 0 | |||
SOX10 | 黑色素瘤 | 维莫非尼, | 1 | 1 | |
SOX14 | 0 | 0 | |||
SOX17 | 0 | 0 | |||
SOX2 | 0 | 0 | |||
SOX21 | 0 | 0 | |||
SOX4 | 0 | 0 | |||
SOX9 | 0 | 0 | |||
SPC24 | 0 | 0 | |||
SPEN | 0 | 0 | |||
SPG7 | 0 | 0 | |||
SPHK1 | 宫颈癌 | 1 | 1 | ||
SPHKAP | 0 | 0 | |||
SPINK1 | 0 | 0 | |||
SPOP | 0 | 0 | |||
SPOPL | 0 | 0 | |||
SPRED1 | 0 | 0 | |||
SPRR3 | 0 | 0 | |||
SPRY2 | 胃腺癌 | 1 | 1 | ||
SPRY4 | 0 | 0 | |||
SPSB4 | 0 | 0 | |||
SPTA1 | 0 | 0 | |||
SRC | 0 | 0 | |||
SRCAP | 0 | 0 | |||
SRD5A2 | 0 | 0 | |||
SRGAP1 | 0 | 0 | |||
SRGAP3 | 0 | 0 | |||
SRMS | 0 | 0 | |||
SRP19 | 0 | 0 | |||
SRSF2 | 急性髓性白血病 | 1 | 1 | ||
SRSF7 | 0 | 0 | |||
SRY | 0 | 0 | |||
SS18 | 0 | 0 | |||
SSTR2 | 0 | 0 | |||
SSX1 | 周围神经鞘恶性肿瘤,滑膜肉瘤 | 1 | 7 | ||
SSX2 | 滑膜肉瘤 | 1 | 4 | ||
SSX4 | 滑膜肉瘤 | 1 | 1 | ||
ST3GAL3 | 0 | 0 | |||
ST6GAL2 | 0 | 0 | |||
ST6GALNAC3 | 0 | 0 | |||
STAG1 | 0 | 0 | |||
STAG2 | 急性髓性白血病,膀胱癌,膀胱尿路上皮乳头状癌,骨尤因肉瘤,黑色素瘤 | 维莫非尼, | 2 | 5 | |
STAG3 | 黑色素瘤 | 维莫非尼, | 1 | 1 | |
STARD4 | 0 | 0 | |||
STAT1 | 0 | 0 | |||
STAT2 | 0 | 0 | |||
STAT3 | T细胞大颗粒淋巴细胞白血病 | 1 | 1 | ||
STAT4 | 0 | 0 | |||
STAT5A | 0 | 0 | |||
STAT5B | 0 | 0 | |||
STAT6 | 0 | 0 | |||
STK11 | 乳腺癌,肺腺癌,非小细胞肺癌,胰腺癌,Peutz-Jeghers综合征,前列腺癌 | CI-1040,依维莫司,依西美坦,派姆单抗(帕博利珠单抗),纳武单抗(纳武利尤单抗),阿特朱单抗,阿替利珠单抗,西罗莫司,SB202190,司美替尼,Sirolimus, | 多西他赛, | 7 | 17 |
STK19 | 0 | 0 | |||
STK24 | 0 | 0 | |||
STK4 | 0 | 0 | |||
STK40 | 0 | 0 | |||
STMN1 | 子宫内膜癌 | 紫杉醇, | 1 | 1 | |
STRBP | 0 | 0 | |||
STT3A | 0 | 0 | |||
SUB1 | 0 | 0 | |||
SUCLG1 | 0 | 0 | |||
SUCLG2 | 0 | 0 | |||
SUFU | 髓母细胞瘤 | 索尼德吉, | 1 | 1 | |
SUGCT | 0 | 0 | |||
SULT1A1 | 0 | 0 | |||
SUZ12 | 0 | 0 | |||
SVEP1 | 0 | 0 | |||
SYK | 卵巢癌 | 紫杉醇, | 1 | 1 | |
SYNCRIP | 0 | 0 | |||
SYNE1 | 0 | 0 | |||
TACC2 | 0 | 0 | |||
TACC3 | 0 | 0 | |||
TAF1 | 0 | 0 | |||
TAF15 | 0 | 0 | |||
TAF1L | 0 | 0 | |||
TAGAP | 0 | 0 | |||
TAL1 | 0 | 0 | |||
TAP1 | 0 | 0 | |||
TAP2 | 0 | 0 | |||
TBC1D8B | 0 | 0 | |||
TBK1 | 黑色素瘤 | AZ909,司美替尼, | 1 | 1 | |
TBL1XR1 | 0 | 0 | |||
TBL3 | 0 | 0 | |||
TBP | 0 | 0 | |||
TBX15 | 0 | 0 | |||
TBX22 | 0 | 0 | |||
TBX3 | 0 | 0 | |||
TCEB1 | 0 | 0 | |||
TCERG1 | 0 | 0 | |||
TCF12 | 0 | 0 | |||
TCF3 | 0 | 0 | |||
TCF4 | 0 | 0 | |||
TCF7L2 | 0 | 0 | |||
TCL1A | 0 | 0 | |||
TCP11 | 0 | 0 | |||
TDG | 0 | 0 | |||
TDO2 | 0 | 0 | |||
Tec | 0 | 0 | |||
TECPR2 | 0 | 0 | |||
TEK | 0 | 0 | |||
TEKT4 | 0 | 0 | |||
TENM3 | 0 | 0 | |||
TENT5C | 0 | 0 | |||
TERC | 0 | 0 | |||
TERT | Acral扁豆状黑色素瘤,脑胶质瘤,透明细胞肾细胞癌,多形胶质母细胞瘤,乳头状甲状腺癌,儿童低级别胶质瘤(PLGG),皮肤黑色素瘤,甲状腺癌 | I-131,U0126, | 5 | 15 | |
TET1 | 0 | 0 | |||
TET2 | 急性髓性白血病,骨髓增生异常综合征 | 1 | 6 | ||
TEX12 | 0 | 0 | |||
TF | 黑色素瘤 | 维莫非尼, | 1 | 1 | |
TFDP1 | 0 | 0 | |||
TFDP2 | 0 | 0 | |||
TFE3 | 0 | 0 | |||
TFF3 | 乳腺癌 | 氨鲁米特,他莫昔芬, | 1 | 1 | |
TFG | 0 | 0 | |||
TG | 0 | 0 | |||
TGFA | 头颈部鳞状细胞癌 | 1 | 1 | ||
TGFB1 | 0 | 0 | |||
TGFBR1 | 0 | 0 | |||
TGFBR2 | 0 | 0 | |||
TGFBR3 | 前列腺癌 | 1 | 1 | ||
TGM2 | 0 | 0 | |||
THADA | 0 | 0 | |||
THBS1 | 0 | 0 | |||
THBS2 | 结直肠癌 | 1 | 1 | ||
THRAP3 | 0 | 0 | |||
THRB | 0 | 0 | |||
TIE1 | 0 | 0 | |||
TIMM8B | 0 | 0 | |||
TIMP1 | 乳腺癌 | 氟维司群, | 紫杉醇, | 1 | 2 |
TIPARP | 0 | 0 | |||
TJP1 | 0 | 0 | |||
TLE1 | 0 | 0 | |||
TLK2 | 乳腺癌 | GF109203X,Go6983, | 1 | 1 | |
TLL1 | 0 | 0 | |||
TLL2 | 0 | 0 | |||
TLR4 | 0 | 0 | |||
TLX3 | 0 | 0 | |||
TMEM127 | 0 | 0 | |||
TMEM132D | 0 | 0 | |||
TMEM67 | 0 | 0 | |||
TMPRSS15 | 0 | 0 | |||
TMPRSS2 | 0 | 0 | |||
TNF | 0 | 0 | |||
TNFAIP3 | 0 | 0 | |||
TNFRSF11A | 0 | 0 | |||
TNFRSF14 | 0 | 0 | |||
TNFRSF17 | 0 | 0 | |||
TNFRSF19 | 0 | 0 | |||
TNFRSF8 | 0 | 0 | |||
TNFSF11 | 0 | 0 | |||
TNFSF13B | 0 | 0 | |||
TNK2 | 0 | 0 | |||
TNKS | 0 | 0 | |||
TNKS2 | 0 | 0 | |||
TNN | 0 | 0 | |||
TNPO1 | 0 | 0 | |||
TNR | 0 | 0 | |||
TNRC18 | 0 | 0 | |||
TOE1 | 0 | 0 | |||
TOP1 | 结直肠癌,卵巢癌 | 卡铂,环磷酰胺,伊立替康,拓扑替康, | 2 | 3 | |
TOP2A | 乳腺癌 | 多柔比星, | 1 | 1 | |
TOP2B | 0 | 0 | |||
TOP3A | 0 | 0 | |||
TOPBP1 | 0 | 0 | |||
TP53 | 急性髓细胞白血病,肾上腺皮质癌,乳腺癌,癌症,宫颈癌,慢性淋巴细胞白血病,CLL/SLL,结直肠癌,食管癌,食管鳞状细胞癌,胃腺癌,头颈鳞状细胞癌,白血病,李夫琅梅尼综合征,肺腺癌癌细胞瘤,肺癌,非小细胞肺癌,淋巴瘤,骨髓增生异常综合征,骨髓瘤,神经母细胞瘤,少突胶质瘤,口腔鳞状细胞癌,卵巢癌,前体B淋巴细胞淋巴瘤/白血病,唾液腺粘液腺癌,肉瘤,皮肤鳞状细胞癌,胃癌胃癌,华登斯特巨球蛋白血症 | Adjuvant Chemotherapy,阿仑单抗,AMGMDS3,硼替佐米,卡培他滨,西妥昔单抗,Chemotherapy,EAP Protocol,Nutlin-3a,帕唑帕尼,培唑帕尼,RG7112,司美替尼,维莫非尼,维奈妥拉/维耐托克, | 卡铂,顺铂,多西他赛,多柔比星,依托泊苷,丝裂霉素,奥沙利铂,他莫昔芬, | 53 | 138 |
TP53BP1 | 0 | 0 | |||
TP63 | 0 | 0 | |||
TP73 | 0 | 0 | |||
TPH1 | 0 | 0 | |||
TPM3 | 0 | 0 | |||
TPMT | 0 | 0 | |||
TPR | 0 | 0 | |||
TPT1 | 黑色素瘤 | Sertraline (INN), | 1 | 1 | |
TPX2 | 0 | 0 | |||
TRA2A | 0 | 0 | |||
TRAF2 | 0 | 0 | |||
TRAF5 | 0 | 0 | |||
TRAF7 | 0 | 0 | |||
TRAP1 | 0 | 0 | |||
TRERF1 | 0 | 0 | |||
TRIM24 | 0 | 0 | |||
TRIM58 | 0 | 0 | |||
TRIO | 0 | 0 | |||
TRPC5 | 0 | 0 | |||
TRPS1 | 0 | 0 | |||
TRRAP | 0 | 0 | |||
TSC1 | 膀胱癌,浸润性膀胱移行细胞癌,非小细胞肺癌,肾细胞癌,结节性硬化症 | 依维莫司,MTOR Inhibitors,西罗莫司, | 3 | 8 | |
TSC2 | 肾细胞癌,甲状腺癌,结节性硬化 | 依维莫司,MTOR Inhibitors, | 2 | 3 | |
TSHR | 0 | 0 | |||
TSHZ2 | 0 | 0 | |||
TSHZ3 | 0 | 0 | |||
TSN | 0 | 0 | |||
TSPYL1 | 前列腺癌 | 1 | 1 | ||
TTF1 | 肺腺癌 | 1 | 1 | ||
TTL | 0 | 0 | |||
TUBA1A | 0 | 0 | |||
TUBA3C | 0 | 0 | |||
TUBB | 0 | 0 | |||
TUBB3 | 乳腺癌,癌症 | Taxane, | 紫杉醇, | 1 | 2 |
TUBB4A | 0 | 0 | |||
TUBB4B | 0 | 0 | |||
TUBB6 | 0 | 0 | |||
TUBD1 | 0 | 0 | |||
TUBE1 | 0 | 0 | |||
TUBG1 | 0 | 0 | |||
TUSC3 | 0 | 0 | |||
TWIST1 | 0 | 0 | |||
TXNIP | 0 | 0 | |||
TXNRD1 | 0 | 0 | |||
TYK2 | 0 | 0 | |||
TYMP | 0 | 0 | |||
TYMS | 癌症,结直肠癌,胃腺癌,肺腺癌,非小细胞肺癌,前列腺癌 | 氟尿嘧啶,伊立替康,甲氨蝶呤,培美曲塞,雷替曲塞, | 5 | 8 | |
TYR | 0 | 0 | |||
TYRO3 | 0 | 0 | |||
TYRP1 | 0 | 0 |